Literature DB >> 8149145

Management of bleeding in a patient with colorectal cancer: a case study.

M Farncombe1.   

Abstract

Superficial bleeding in patients with malignant disease is a distressing symptom, which is often difficult to control. The following is a case study outlining the use of Sucralfate, an oral cytoprotective agent, used topically in a patient with colo-rectal cancer. The treatment resulted in control of bleeding, less localized pain and more freedom and independence for the patient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8149145     DOI: 10.1007/bf00366064

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  3 in total

1.  Control of bleeding in advanced cancer.

Authors:  C F Regnard
Journal:  Lancet       Date:  1991-04-20       Impact factor: 79.321

2.  Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate.

Authors:  R Kochhar; F Patel; A Dhar; S C Sharma; S Ayyagari; R Aggarwal; M K Goenka; B D Gupta; S K Mehta
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

3.  Rectal sucralfate in radiation proctitis.

Authors:  R Kochhar; S C Sharma; B B Gupta; S K Mehta
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.